Thursday, June 1, 2017

Ferring Appoints Aaron Graff to Executive Board

SAINT-PREX, Switzerland -Thursday, June 1st 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer and made a member of the Ferring Group Executive Board, effective immediately.

Aaron Graff joined Ferring in 2002 as Vice President Global Marketing, Business Development, and Medical Affairs, based in Copenhagen, Denmark. After leading the acquisition and integration of Israeli biopharmaceutical company BTG in 2005, he relocated his team to the newly established Ferring International Center in Saint-Prex, Switzerland, where he was promoted to Senior Vice President, Asia Region and Global Marketing. Since 2010, Graff has led Ferring’s U.S. operations from its U.S headquarters in New Jersey, first as Chief Operating Officer and since 2016 as Chief Executive Officer.

“Under Aaron’s leadership in the United States, our U.S. business grew at double-digit rates,” said Michel Pettigrew, President of the Executive Board and Chief Operating Officer, Ferring Pharmaceuticals. “His broad, global professional experience and track record make him uniquely qualified for this important role.”

Prior to joining Ferring, Graff worked at Bristol-Myers Squibb for over 17 years in a variety of sales, marketing and commercial operations management positions.

About Ferring Pharmaceuticals:

Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. A leader in reproductive and maternal health, Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative treatments to help mothers and babies, from conception to birth. The company also identifies, develops and markets innovative products in the areas of urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com.



Contacts

Ferring Pharmaceuticals
Lindsey Rodger
Tel. +41 (0) 58 451 40 23
lindsey.rodger@ferring.com
or
Carine Julen
Tel. +41 58 301 01 78
carine.julen@ferring.com



Permalink : http://me-newswire.net/news/4005/en

Neustar Triples Global DDoS Defence Network Mitigation Capacity to More Than 4 Tbps Including EMEA and Singapore

EMEA nodes expanded to over 1Tbps of regional capacity distributed across Frankfurt, Amsterdam and London

STERLING, Va.-Thursday, June 1st 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Neustar, Inc. (NYSE: NSR), a trusted, neutral provider of real-time information services, today announced that it has tripled its global DDoS mitigation network capacity reaching 4 Tbps across EMEA and Singapore. This places the company within close reach of its goal of a 10 Tbps Global DDoS Defence Network, which will be the world’s largest, most distributed and technically advanced DDoS mitigation defence network, by early 2018.

In EMEA, Neustar has significantly expanded network capacity with an increase of 244 percent from 320 Gbps to more than 1 Tbps distributed across three nodes in Frankfurt, Amsterdam and London alone. APAC also has a new 200 Gbps node in Singapore, doubling the in-region capacity with additional large nodes soon following. By Q1 2018, the Neustar Global DDoS Defence Network will have 27 nodes distributed across all regions.

“We are changing the model from a handful of scrubbing centres to a globally scaled distributed model. This is a big departure from when I started the DDoS defence industry,” said Barrett Lyon, Head of Security Research and Development. “The capacity of our network will enable Neustar to offer unrivalled mitigation capability and network performance to keep our customers protected against any type of DDoS attack.”

Delivering In-Region Detection & Mitigation at Scale

The expansion of Neustar’s global DDoS mitigation network meets the scale and demands required to thwart modern DDoS attacks and deliver future-proof levels of protection due to its construction design, implementation and capacity. This fast-growing network of dedicated in-region mitigation centres will also enable Neustar to improve traffic routing performance for customers during attacks. With an increased number of local detection and mitigation centres, Neustar is able to redirect traffic to local scrubbing centres at the edge of the network, closer to the source. By scrubbing a customer’s web traffic and redelivering it locally rather than having to be backhauled to a scrubbing centre that may be partway around the world, Neustar offsets latency and restores network performance more quickly and effectively resulting in faster, more efficient in-region mitigation and greater customer value.

“The construction of our new DDoS network with regionalized nodes is a game-changer for our customers,” says Lyon. “We now have the capability to meet and defeat new attacks head-on, with localized scrubbing, so customers don’t feel the impact to their networks. What we are building is the proper evolution and sophistication of DDoS defence and it’s unlike anything that is available on the market today”.

About Neustar Security Solutions

Security Solutions defend against network threats, inform you of potential network vulnerabilities, accelerate online asset performance, and monitor client website performance through multiple services and offerings. Neustar will offer the largest, most distributed DDOS mitigation network in the world with over 10 Tbps of capacity, and our industry leading SiteProtect DDoS protection service ensures full coverage in an attack. Our UltraDNS service manages 10% of all internet traffic, routes over 1T queries a month and provides industry leading uptime and 100% website availability. Neustar’s IP Intelligence is the authoritative source of IP decisioning data on 99.99% of routable IP addresses worldwide. Our 19+ years of unparalleled expertise ensures that our customers are protected and optimized during normal business practices and when unsolicited events occur. Our services ensure customers network connectivity are protected and optimized whether in crisis or just business as usual. We are trusted by many of the world’s largest brands to keep their mission critical systems up and running.

About Neustar

Every day, the world generates roughly 2.5 quadrillion bits of data. Neustar (NYSE: NSR) isolates certain elements and analyzes, simplifies and edits them to make precise and valuable decisions that drive results. As one of the few companies capable of knowing with certainty who is on the other end of every interaction, we’re trusted by the world’s great brands to make critical decisions some 20 billion times a day. We help marketers send timely and relevant messages to the right people. Because we can authoritatively tell a client exactly who is calling or connecting with them, we make critical realtime responses possible. And the same comprehensive information that enables our clients to direct and manage orders also stops attackers. We know when someone isn’t who they claim to be, which helps stop fraud and denial of service before they’re a problem. Because we’re also an experienced manager of some of the world’s most complex databases, we help clients control their online identity, registering and protecting their domain name, and routing traffic to the correct network address. By linking the most essential information with the people who depend on it, we provide more than 11,000 clients worldwide with decisions—not just data. More information is available at https://www.neustar.biz

Contacts

Neustar Media Contact
AxiCom for Neustar EMEA
Laura Cahill
NeustarSec@axicom.com


أندرسن تاكس آند ليجال تنطلق في ألمانيا

Image not foundسان فرانسيسكو -يوم الخَمِيس 1 يونيو 2017 [ إم إي نيوز واير ]

(بزنيس واير): تفخر "أندرسن جلوبال" بإعلان انطلاق اسم "أندرسن" في ألمانيا مع إضافة الشركة الجديدة العضو "أندرسن للاستشارات القانونية والضريبية" في كولونيا بألمانيا. وينضمّ الفريق المؤلف من عشرة أشخاص إلى "أندرسن جلوبال"  بشكل أساسي من شركة "لوثر" للمحاماة وسيقدّم خدمات متعلقة بالضرائب والشؤون القانونية تحت اسم "أندرسن تاكس آند ليجال"، وبقيادة كل من ستيفن كراوس وهيرمن نوت.
وقال مارك فورساتز، الرئيس التنفيذي لشركة "أندرسن تاكس": "تُعدّ ألمانيا واحدةً من الأسواق الرئيسية في العالم وتؤكد إضافة الفريق في كولونيا مدى التزامنا بوضع توسّع منصتنا في ألمانيا على رأس أولوياتنا. ويعتبر ستيفن وهيرمن من الشركاء المؤسسين لشركة ’أندرسن ليجال‘ في ألمانيا، وشغل ستيفن منصب الشريك الإداري لشركة ’لوثر‘ للمحاماة لمدّة 15 عاماً. ويتمتع الفريق في كولونيا بخبرة وقيم وثقافة ’أندرسن‘ التي لا تزال تؤدي دوراً غاية في الأهمية في عملية تطوير نموذج سلس للخدمات المهنية".
ويعد المكتب في كولونيا هو الشركة الأولى التي ستعتمد اسم "أندرسن" في ألمانيا والموقع الثالث في ألمانيا، حيث انضمّت "أليجيس"، بقيادة الشريك الإداري أليسيو روسي في عام 2015 مع موقعين في دوسلدورف ومرتسيغ. وستعمل المواقع الثلاثة في نهاية المطاف تحت اسم "أندرسن تاكس آند ليجال".
وقال ستيفن كراوس، الذي سيشغل مع أليسيو روسي منصب الشريك الإداري لدى "أندرسن تاكس آند ليجال" في ألمانيا: "انضممنا إلى ’أندرسن تاكس آند ليجال‘ لأننا نتقاسم تاريخاً مشتركاً وقيماً جوهرية وأردنا أن نكون جزءاً من الشركة الضريبية والقانونية العالمية متعددة التخصصات. ويصب الجمع بين الخدمات الضريبية والقانونية الأفضل في فئتها بشكل واضح في مصلحة عملائنا".
ستقدّم "أندرسن تاكس آند ليجال" في كولونيا مجموعة واسعة من الخدمات القانونية المؤسسية والتجارية بما في ذلك صفقات الاندماج والاستحواذ، والخدمات التنظيمية المصرفية والمالية، والخدمات العقارية وتسوية النزاعات فضلاً عن الخدمات الضريبية للأفراد والمؤسسات في ألمانيا والشؤون العابرة للحدود.
هذا وتوظف "أندرسن العالمية" أكثر من ألفي خبير في 64 موقعاً في جميع أنحاء العالم، وذلك من خلال الشركات الأعضاء والشركات المتعاونة.

إن نص اللغة الأصلية لهذا البيان هو النسخة الرسمية المعتمدة. أما الترجمة فقد قدمت للمساعدة فقط، ويجب الرجوع لنص اللغة الأصلية الذي يمثل النسخة الوحيدة ذات التأثير القانوني.


Contacts
شركة "أندرسن تاكس"
ميجان تسوي
هاتف: 
4157642700

الرابط الثابت : http://www.me-newswire.net/ar/news/4002/ar

Andersen Tax & Legal Launches in Germany

Image not foundSAN FRANCISCO -Thursday, June 1st 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Andersen Global is proud to announce the launch of the Andersen name in Germany with the addition of a new member firm, Andersen Rechtsanwaltsgesellschaft Steuerberatungsgesellschaft mbH, in Cologne, Germany. The team of ten joins Andersen Global primarily from Luther law firm, and will provide tax and legal services under the name Andersen Tax & Legal. The team is led by Stefan Kraus and Hermann Knott.
“Germany is one of the key markets in the world and the addition of the team in Cologne demonstrates our commitment to making the expansion of our platform there a top priority,” said Andersen Tax CEO, Mark Vorsatz. “Stefan and Hermann were among the founding partners of Andersen Legal in Germany and Stefan was Managing Partner of Luther law firm for 15 years. The team in Cologne brings with them the experience, values and culture of Andersen that continues to play a very important role in our development of a seamless professional services model.”
The office in Cologne is the first to adopt the Andersen name in Germany but the third location in Germany. Alegis, led by Managing Partner Alessio Rossi, joined Andersen Global in 2015 with locations in Dusseldorf and Merzig. Eventually, all three locations will operate as Andersen Tax & Legal.
“We joined Andersen Tax & Legal because we share a history and core values and wanted to be a part of a globally operating multidisciplinary tax and legal firm,” shared Stefan Kraus who, together with Alessio Rossi, will serve as Managing Partners for Andersen Tax & Legal in Germany. “The combination of best-in-class tax and legal services is clearly a benefit for our clients.”
Andersen Tax & Legal in Cologne will provide a large range of corporate and commercial legal services including M&A transactions, banking and finance regulatory services, real estate and dispute resolution as well as individual and corporate tax services in Germany and on cross-border matters.
Andersen Global has more than 2,000 professionals worldwide and a presence in 64 locations through its member firms and collaborating firms.

Contacts
Andersen Tax
Megan Tsuei, 415-764-2700

MENA Energy Clarifies Its Position Regarding Dispute with Hascol Petroleum and the Subsequent High Court Ruling

MENA Energy DMCC: Update regarding High Court Judgement MENA Energy DMCC v Hascol Petroleum Ltd


Dubai, United Arab Emirates -Thursday, June 1st 2017 [ ME NewsWire ]

A statement by MENA Energy:

On 16 February 2017, the England and Wales High Court ruled that MENA Energy is entitled for damages from Hascol Petroleum concerning two shipments of fuel oil and one shipment of gas oil to Karachi in November 2014. Counterclaims bought forward by Hascol Petroleum have been dismissed.
   
Despite the ruling of the England and Wales High Court of Justice, reports that there is no case underway between MENA Energy and Hascol Petroleum or that Hascol Petroleum is entitled for damages are false.
   
The High Court will convene again to determine MENA's damages claim, which totals approximately US$15 million inclusive of interests and legal costs.
   
The proceedings were in the England and Wales High Court and not arbitration. The complete judgment can be accessed at: www.bailii.org/ew/cases/EWHC/Comm/2017/262.html

MENA Energy DMCC (“MENA”), a fully-integrated and independent energy trading company headquartered in Dubai, UAE, wishes to clarify its position on the oil trading dispute between MENA and Hascol Petroleum Ltd ("Hascol").

The dispute relates to the transactions for the sale of fuel oil and gasoil (diesel) by MENA to Hascol in Pakistan, for shipment in November/ December 2014, when there was a sharp decline in oil prices. Hascol defaulted on its performance obligations under the contracts.

On 16 February 2017, The England and Wales High Court of Justice (Commercial Court) handed down judgment on the liability of the dispute between MENA and Hascol. The Court ruled that MENA were completely successful with its liability claim and also dismissed the counterclaims of Hascol with regards to each of the fuel oil and gasoil shipments.

In the next hearing MENA's damages claim which totals approximately US$15 million inclusive of interests and legal costs, will be determined. Hascol has no damages claims to be determined.

Rashid Al Ghurair, CEO of MENA Energy commented:

“MENA Energy believes in a partnership based approach while working with our clients. The relationships we have formed are based on the cornerstones of trust, integrity and business ethics.

“We have a responsibility to our stakeholders and the oil trading industry to ensure commitments are honoured and clients do not blatantly default on their performance obligations. After multiple attempts to resolve this issue privately we were left with no other option but to resolve this matter through the courts.”

Contacts

Grayling
Jonathan Shillington, +971522294603
jonathan.shillington@grayling.com


Permalink : http://me-newswire.net/news/3997/en

شيلتيرن تستحوذ على شركة إنتجرايد ديفالوبمنت أسوشييتس ليمتد، منظمة الأبحاث السريرية اليابانية

Image not foundلندن وويلمينغتون، كارولينا الشمالية وطوكيو-يوم الأَرْبعاء 31 مايو 2017 [ إم إي نيوز واير ]

(بزنيس واير): استحوذت "شيلتيرن"، وهي المنظمة العالمية الرائدة في مجال الأبحاث العالمية القائمة على العقود، على شركة "إنتجرايد ديفالوبمنت أسوشييتس ليمتد" ("آي دي إيه")، منظمة الأبحاث السريرية المتخصصة في دمج اليابان وآسيا في مجال تطوير الأدوية على الصعيد العالمي.

وبفضل طاقم عملها الموزّع  في كلّ من اليابان وكوريا وجنوب شرق آسيا، تتمتع "آي دي إيه" بخبرة واسعة في إنشاء مسارات تنظيمية وتنموية لليابان وتنفيذ تجارب سريرية لعموم آسيا سعياً لتحقيق الأهداف التنظيمية اليابانية والعالمية معاً. وستساهم تجربة "آي دي إيه" في مجموعة واسعة من المجالات العلاجية ومعرفتها وعلاقاتها المحلية بتزويد شركة "شيلتيرن" بإمكانية تقديم مقاربات مثلى لدمج اليابان وآسيا في تطوير الأدوية على الصعيد العالمي. وبالإضافة إلى ذلك، تقدم عملية الاستحواذ فرصاً أمام الشركات اليابانية لدخول سوق أوسع من خلال الاعتماد على خبرة  "شيلتيرن" وعلاقاتها العالمية.

وقال الدكتور جيم إسينهارت، الرئيس التنفيذي لشركة "شيلتيرن": " ينطلق  الاستحواذ على ‘آي دي إيه’ من التزامنا بتأسيس حضور هام لنا في كافة الأسواق العالمية الرئيسية ودعم عملائنا من خلال قدرات التنمية السريرية في كافة أنحاء العالم. وتعدّ منطقة اليابان وجنوب شرق آسيا من بين أكبر وأسرع أسواق الأدوية نمواً في العالم. وستمكننا ‘آي دي إيه’ من النمو في منطقة آسيا والمحيط الهادئ من خلال إقامة علاقات راسخة وخبرات ومعارف محلية. "

ستعمل "آي دي إيه"، كشركة تابعة مملوكة بالكامل لشركة "شيلتيرن"، وسيُعاد تسميتها "آي دي إيه"، شركة تابعة لـ"شيلتيرن". وبموجب هذه الاتفاقية، سيواصل جون واينبارجر الرئيس التنفيذي لشركة "آي دي إيه" قيادة الشركة.  يتمتع واينبارجر بأكثر من 30 عاماً من الخبرة في العمل في اليابان، وسوف ينضم إلى فريق قيادة "شيلتيرن".

لمعرفة المزيد حول خدمات التطوير السريري العالمية التي توفّرها شركة "شيلتيرن"، يرجى زيارة الموقع الإلكتروني التالي: Chiltern.com.

لمحة عن "شيلتيرن"

تعتبر "شيلتيرن"، منظمة الأبحاث العالمية القائمة على العقود، إحدى الشركات الرائدة في مجال توفير الخدمات السريرية والعلاجات في مجموعة متنوعة من المجالات العلاجية مع نماذج مشاركة من القطاعات الصيدلانية البيولوجية والأجهزة الطبية. يوفر فريق "شيلتيرن" المؤلف من أكثر من 4300 فرد والمتمركز في 47 دولة بشكل شامل تنمية سريرية وشؤوناً طبية وعلمية وبيانات وتحليل وسلامة دوائية وخدمات تنظيمية إستراتيجية باستخدام مقاربة تعاونية للتجارب السريرية الأكثر فعالية. بإمكانكم زيارة الموقع الإلكتروني Chiltern.com لمعرفة كيف تتمحور خدمات "شيلتيرن" حولكم".

إن نص اللغة الأصلية لهذا البيان هو النسخة الرسمية المعتمدة. أما الترجمة فقد قدمت للمساعدة فقط، ويجب الرجوع لنص اللغة الأصلية الذي يمثل النسخة الوحيدة ذات التأثير القانوني.

Contacts

"إس سي أو آر آر" التسويق لصالح "شيلتيرن"

ليا ستودر

هاتف: 13082375567+

البريد الإلكتروني: lea@scorrmarketing.com



الرابط الثابت : http://me-newswire.net/ar/news/4001/ar

Chiltern Acquires Japanese Clinical Research Organization Integrated Development Associates Co. Ltd.

Image not foundLONDON & WILMINGTON, N.C. & TOKYO-Wednesday, May 31st 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Chiltern, a leading global contract research organization, has acquired Integrated Development Associates Co. Ltd. (IDA), a CRO specializing in integrating Japan and Asia into global drug development.

With staff based in Japan, Korea and Southeast Asia, IDA has extensive expertise in establishing regulatory and development pathways for Japan and implementing Pan Asian clinical trials to achieve both Japanese and global regulatory objectives. IDA’s experience in a broad range of therapeutic areas and its local knowledge and relationships will allow Chiltern to offer optimal approaches for integrating Japan and Asia into global drug development. In addition, the acquisition opens opportunities for Japanese companies to enter a wider market by relying on Chiltern’s global expertise and connections.

“The acquisition of IDA is driven by our commitment to establish a substantial presence in all major global markets and support our clients with clinical development capabilities worldwide,” said Jim Esinhart, Ph.D., Chiltern CEO. “Japan and Southeast Asia are among the world’s largest and fastest-growing pharmaceutical markets. IDA will enable us to grow in the APAC region through well-established relationships and local expertise and knowledge.”

IDA will do business as a wholly owned subsidiary of Chiltern and be renamed IDA, a Chiltern Company. As a part of this agreement, IDA’s founder and CEO, John Winebarger, will continue to lead IDA. Winebarger has more than 30 years’ experience working in Japan and will join Chiltern’s leadership team.

To learn more about Chiltern’s global clinical development services, visit Chiltern.com.

About Chiltern
Chiltern, a global contract research organization, is a leading provider of clinical services and solutions in a variety of therapeutic areas with engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,300, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance and Strategic Regulatory services using a collaborative approach for more efficient clinical trials. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®.

Contacts

SCORR Marketing for Chiltern
Lea Studer, +1-308-237-5567
lea@scorrmarketing.com

Permalink : http://me-newswire.net/news/4001/en